Jyong Biotech LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Ms. Kuo Fu-Feng and associated entities disclose a 33.34% beneficial ownership stake in Jyong Biotech Ltd.